CN1061983C - 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof - Google Patents

4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof Download PDF

Info

Publication number
CN1061983C
CN1061983C CN96116595A CN96116595A CN1061983C CN 1061983 C CN1061983 C CN 1061983C CN 96116595 A CN96116595 A CN 96116595A CN 96116595 A CN96116595 A CN 96116595A CN 1061983 C CN1061983 C CN 1061983C
Authority
CN
China
Prior art keywords
trifluoromethyl
ketone
steroid compound
keto
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96116595A
Other languages
Chinese (zh)
Other versions
CN1161972A (en
Inventor
费向曙
田伟生
陈庆云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN96116595A priority Critical patent/CN1061983C/en
Publication of CN1161972A publication Critical patent/CN1161972A/en
Application granted granted Critical
Publication of CN1061983C publication Critical patent/CN1061983C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

The present invention relates to compounds 4-trifluoromethyl-3-ketone-steroid and a preparation method thereof. The compounds are androsteroid, progesteroid or spirosteroid compounds of 4-olefine, 1, 4-diolefine or 4, 6-diolefine; a trifluoromethylation reaction of 4-bromine or iodine-3-ketone-4-olefine-steroid produces an intermediate product 4-trifluoromethyl-3-ketone-4-alkene-steroid; the intermediate product further reacts with benzoquinone compounds to produce 4-trifluoromethyl-3-ketone-1, 4 or 4, 6-olefine-steroid. The method for synthesizing trifluoromethyl steroids provided by the present invention is convenient and effective.

Description

A kind of 4-trifluoromethyl-3-ketosteroid compound and synthetic method thereof
The present invention relates to a kind of fluorine-containing steroidal compounds.Be 4-trifluoromethyl-3-ketosteroid compound and synthetic, comprise its female steroid, androstane, pregnant steroid or spiral shell steroid compound.
At first,, in the organic active molecule, introduce fluorine, can cause noticeable change [P.Goldman, Science, 1969,64,1123 of molecular chemistry, physics and physiologically active because the fluorine element element has unique character; Biomedical Aspects of Fluorine Chemistry, R.Filler and Y.Kobayashi, Kodansha Ltd., Tokyo, 1980.].In the steroidal molecule, introduce the noticeable change that fluorine can cause physiologically active equally, as the high 10-12 of specific activity nonfluorinated cortisone that fluoridizes cortisone [J.Fried and E.F.Sabo doubly, J.Am.Chem.Soc., 1954,76,1455], therefore introducing fluorine in the steroidal molecule is an important channel seeking the steroidal new drug.Because trifluoromethyl has very high electronegativity, stability and lipotropy, therefore change of properties is more obvious after introducing trifluoromethyl usually in the steroidal molecule, as trifluoro angular methyl(group) steroidal is a kind of good aromatization enzyme inhibitor [Hideo Nemoto etal, J.Org.Chem., 1,995 60,594], the activity of 17-trifluoromethyl-testosterone be three times of anti-early pregnancy drug RU486 (Wang Zhongqi, Lu Shoufu, ZL93112563.4).But synthetic trifluoromethyl steroidal is than a synthetic fluorine, the more difficult [J.Fried of difluoro steroidal, N.A.Abraham, Organic Reaction in Steroid Chemistry, New York, 1972, Vol.1, pp423-493], particularly on heterocycle, introduce the steroidal synthetic of trifluoromethyl group and report seldom.Generally be photoresponse [A.F.Pascual and M.E.Wolff, J.Med.Chem., 1971 of adopting CF3I and steroidal, 14,164], be illustrated in fig. 1 shown below photoresponse [the G.H.Rasmusson et al J.Org.Chem. that has reported CF3I and steroidal, 1975,40,672]
Figure 9611659500051
A, R=β-OAc, α-H b, R=β-COCH3, α-OAc
But transformation efficiency has only 32-42%.Therefore the method for bibliographical information not only the time long, operational difficulty, and productive rate is very low.Secondly also have the CF3SiMe3 of employing and carbonyl reaction [J.Fluorine Chem., Z.Q.Wang, etal, 1994,69,1), but be subjected to steric influence bigger.The 3-ketosteroid compound is a known drug, introduce bromine or iodine at C4, with 3-carbonyl-4-en steroids in the mixed solvent of acetate, ether, with the trimethylpyridine is proton acceptor, can only generate 4-bromine or iodine-3-ketone-4-en steroids compound (D.N.Kirk, etal, J.Chem.Soc., 1956,627).We on this basis, obtain the product that halogen is replaced by trifluoromethyl under the suitable condition by experiment, promptly obtain more high reactivity new class compound: the 4-trifluoromethyl-3-ketosteroid compound, and, find out efficient, easy synthetic method at the deficiency of aforesaid method.
Purpose of the present invention just provides the highly active new steroidal compounds of a class: the 4-trifluoromethyl-3-ketosteroid compound, and a kind of method of synthetic 4-trifluoromethyl-3-ketosteroid compound simply, efficiently is provided.
4-trifluoromethyl-3-ketosteroid compound provided by the invention has following general molecular formula:
Figure 9611659500061
R wherein 1=H or CH 3, R 2=H or O, R 3=H, CH 3Or C 2H 5, R 4=OH, CH 3CO, CH 3COO, CONR7R8 or C 1-10Alkyl, R 5=H, CH 3Or CH 3COO, R 4And R 5=O, OCH 2CH 2O or R 6=H or CH 3, R 5And R 6=O, R 7Or R 8=H, C 1-10Alkyl, cycloalkyl, R 7And R 8=(CH 2) n, n=1-6,
Figure 9611659500063
Figure 9611659500064
It can be female steroid, androstane, pregnant steroid or the spiral shell steroid compound of 4-alkene, 1,4-diene or 4,6-diene.As 4-Trifluoromethyl-1 7 beta-hydroxy androstane-4-alkene-3-ketone, 4-Trifluoromethyl-1 7 beta-hydroxyl-17 alphas-methyl androstane-4-alkene-3-ketone-17-acetic ester, 4-trifluoromethyl androstane-4-alkene-3,11, the 17-triketone, 4-trifluoromethyl-N-sec.-propyl androstane-4-alkene-3-ketone-17 β-methane amide, 4-Trifluoromethyl-1 3-ethyl androstane-4-alkene-3, the 17-diketone, 4-Trifluoromethyl-1 3-ethyl androstane-1,4-alkene-3, the 17-diketone, 4-Trifluoromethyl-1 7 beta-hydroxies female steroid-4-alkene-3-ketone, 4-Trifluoromethyl-1 7 beta-hydroxyl-17 alphas-methyl female steroid-3-ketone, 4-Trifluoromethyl-1 6 α, the pregnant steroid of 17 α-epoxy-4-alkene-3-ketone, the pregnant steroid of 4-Trifluoromethyl-1 7 beta-hydroxies-16 Alpha-Methyl-4-alkene-3-ketone-17-acetic ester, the pregnant steroid of 17 beta-hydroxies-4-trifluoromethyl-4-alkene-3-ketone-21-hydroxy acid lactone, 4-trifluoromethyl androstane-4,6-diene-3, the 17-diketone-, 4-trifluoromethyl-N-sec.-propyl androstane-1,4-diene-3-ketone-17 β-methane amide, 4-Trifluoromethyl-1 3-ethyl androstane-4,6-diene-3, the 17-diketone, 4-trifluoromethyl androstane-4,6-diene-3, the 17-diketone, 4-trifluoromethyl female steroid-1,4-diene-3, the 17-diketone, 4-trifluoromethyl androstane-1,4-diene-3, the 17-diketone, 4-trifluoromethyl-N-(1, the 1-dimethyl ethyl) androstane-4,6-diene-3-ketone-17 β-methane amide, 4-trifluoromethyl-N-sec.-propyl androstane-4,6-diene-3-ketone-17 β-methane amide, 4-trifluoromethyl-N-sec.-propyl female steroid-1,4-diene-3-ketone-17 β-methane amide, (25R)-4-trifluoromethyl spiral shell steroid-4-alkene-3-ketone etc.
The method that the present invention also provides a kind of simple and effective to prepare above-mentioned 4-trifluoromethyl-3-ketosteroid compound promptly with molecular formula is:
Figure 9611659500071
4-bromine or iodine-3-ketone-4-alkene-sterides compound raw material, wherein R 1=H, CH 3, R 2=H or O, R 3=H, CH 3Or C 2H 5, R 4=OH, CH 3CO, CH 3COO, CONR 7R 8Or C 1-10Alkyl, R 5=H, CH 3Or CH 3COO, R 4And R 5=O, OCH 2CH 2O or, R 6=H or CH 3, R 5And R 6=O, R 7Or R 8=H, C 1-10Alkyl or cycloalkyl, R 7And R 8=(CH2) n, n=1-6,
Figure 9611659500072
In solvent, with CuI or Cu powder is catalyzer, with 4-bromine or iodine-3-ketone-4-alkene-steroidal and trifluoromethyl reagent reaction, because trifluoromethyl reagent can generate corresponding trifluoromethylation product with alkene halogen, fragrant halogen and allyl halide reaction, therefore get product: 4-trifluoromethyl-3-ketone-4-en steroids, productive rate good (yield is 70～93%).Reaction formula is as shown in Figure 2:
A: trifluoromethyl reagent, CuI or Cu powder, solvent, 40-80 ℃ of .R=C 2H 5, CH 3, H
B: benzene or dioxane, tetrachlorobenzoquinone.
C: the trimethyl carbinol, dichloro dinitrile benzoquinones.
Wherein solvent is ether, sherwood oil, benzene, tetracol phenixin, ethyl ketone, dimethyl sulfoxide (DMSO), hexamethylphosphoramide HMPA, N, dinethylformamide DMF, N,N-dimethylacetamide DMA.Recommending solvent is hexamethylphosphoramide HMPA, N, dinethylformamide DMF, N,N-dimethylacetamide DMA.The mole ratio of 4-bromine or iodine-3-ketone-4-alkene-steroidal, CuI or Cu powder and trifluoromethyl reagent is 1: 0.1-5: 0.5-5, reaction times is 1-10 hour, heating is to help the carrying out that react in the method for the invention, and temperature of reaction depends on reactant and solvent, the temperature of reaction of this reaction is controlled at 30-120 ℃ usually, and the recommendation response temperature is 40-80 ℃.
4-trifluoromethyl-3-ketone-4-en steroids generates 4-trifluoromethyl-3-ketone-1 with dichloro dinitrile benzoquinones reacting by heating in t-butanol solvent, 4-two en steroids, wherein 4-trifluoromethyl-3-ketone-4-en steroids and dichloro dinitrile benzoquinones the reaction mole ratio 1: 0.8-5, the reacting by heating time is 2-8 hour in t-butanol solvent.
4-trifluoromethyl-3-ketone-4-en steroids generates 4-trifluoromethyl-3-ketone-4 with the tetrachlorobenzoquinone reacting by heating in benzene or dioxane solvent, 6-diene steroidal compounds. wherein 4-trifluoromethyl-3-ketone-4-en steroids and tetrachlorobenzoquinone the reaction mole ratio 1: 0.8-5, the reacting by heating time is 2-15 hour in benzene or dioxane solvent.
In the method for the present invention, key is that trifluoromethylation reaction, the used trifluoromethyl reagent of the present invention can represent with general formula, i.e. X (CF 2CF 2O) m(CF 2) kCO 2Y, wherein X=Cl, Br, I or FO 2S, Y=H, CH 3, C 2H 5Or K, m=0 or 1, k=1 or 2.As FO 2SCF 2CO 2CH 3, FO 2SCF 2CO 2C 2H 5, FO 2SCF 2CF 2OCF 2CO 2CH 3, FO 2SCF 2CF 2OCF 2CO 2K, FO 2SCF 2CF 2OCF 2CF 2CO 2CH 3, XCF 2CO 2CH 3, XCF 2CO 2C 2H 5, XCF 2CO 2K etc.
In sum, trifluoro-methyl steroid of the present invention has been compared following significant effect with existing steroidal compounds with method, at first has high physiologically active, carrying out the bioactive Ki value comparison that the enzyme kinetics method is measured as androstane-4-trifluoromethyl-4-alkene-3-ketone-17 beta-diketon and known steroid drugs Proscar, is respectively 28.8 and 54.7.Secondly needn't by with CF 3I carries out photoresponse and expends the plenty of time, and it is brief that yield can be brought up to the 70-93% method steps from 32-42%, easy to operate, and productive rate is good.Required trifluoromethyl reagent is easy to preparation, does not need special conversion unit and reagent.
Following embodiment will help to understand the present invention, but be not limited to content of the present invention:
Embodiment 1
Get 0.43mmol4-bromine courage steroid-4-alkene-3-ketone
Figure 9611659500091
0.05-2mmol Cu powder or CuI, 0.2-2mmol FO 2SCF 2CO 2Me, FO 2SCF 2CF 2OCF 2CO 2K or BrCF 2CO 2CH 3, in 20ml benzene, acetonitrile or DMF solvent, at N 2Following 60-80 ℃ of reaction 4-8 hour, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used 3 * 30mml extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get white solid 4-trifluoromethyl courage steroid-4-alkene-3-ketone after separating with flash column chromatography
Figure 9611659500092
176mg, yield is 90%.m.p.：111.0～112.0℃。IR(KBr?pellet)：2980，2800，2690，1600，1468，1370，1346，1160，1124cm -1。
1H?NMR(300MHz，CDCl 3)d：0.71(s，3H，C 18-H)，0.86(dd，J=6.85，1.13Hz，6H，C 26-H，C 27-H)，0.91(d，J=6.49Hz，3H，C 21-H)，1.25(s，C 19-H)，3.30(d，br，J=14.69Hz，1H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.7(s)ppm。
MS?m/z：454(M ++2，7.07)，453(M ++1，25.62)，452(M +，17.27)，437(M +-CH 3，7.667)，383(M +-CF 3，12.35)，367(7.14)，339(8.88)，297(31.25)，260(64.29)，247(334.44)，192(61.29)，95(66.47)，69(47.91)，43(100)。
Ultimate analysis C 28H 43OF 3Calculated value: C:74.30, H:9.57
Measured value: C:74.59, H:9.97.
Embodiment 2
Get 0.50mmol 4-bromine androstane-4-alkene-3,17-diketone, 0.05-2mmol CuI, 0.3-2.5mmolFO 2SCF 2CO 2C 2H 5, in 20ml N,N-dimethylacetamide DMA solvent, at N 2Following 50-75 ℃ of reaction 6 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 40ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get white solid 4-trifluoromethyl androstane-4-alkene-3 after separating with flash column chromatography, the 17-diketone, and yield is 81%,
m.p.：150.0～151.0℃。
IR(KBr?pellet)：3000，1750，1600，1350，1160，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.93(s，3H，C 18-H)，1.29(s，C 19-H)，3.12(d，br，J=14.82Hz，1H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.7(s)ppm。
MS?m/z：355(M ++1，7.22)，354(M +，30.31)，339(M +-CH 3，7.72)，310(16.16)，285(M +-CF 3，25.44)，268(15.88)，241(17.87)，192(100)，107(78.92)，69(17.69)。
Ultimate analysis: C 20H 25O 2F 3Calculated value: C:67.78, H:7.11
Measured value: C:67.54, H:7.37.
Embodiment 3
Get the pregnant steroid of 0.50mmol 4-bromine-4-alkene-3,21-diketone, 1mmol Cu powder, 2mmolFO 2SCF 2CF 2OCF 2CO 2CH 3, in 20ml hexamethylphosphoramide HMPA solvent, at N 2Following 90-110 ℃ of reaction 2 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get the pregnant steroid of white solid 4-trifluoromethyl-4-alkene-3, the 21-diketone after separating with flash column chromatography.Yield is 74%,
m.p.：124.5～125.5℃。
IR(KBr?pellet)：2950，2800，1700，1600，1460，1364，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.68(s，3H，C 18-H)，1.26(s，C 19-H)，2.21(s，C 21-H)，3.05(d，br，J=14.65Hz，1H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.3(s)ppm。
MS?m/z：382(M +，5.97)，367(M +-Me，10.78)，364(4.26)，339(4.29)，192(49.85)，190(59.01)，173(27.37)，147(64.39)，133(37.37)，43(100).
Ultimate analysis: C 22H 29O 2F 3Calculated value: C:69.09, H:7.64
Measured value: C:69.00, H:8.11.
Embodiment 4
Get the pregnant steroid of 0.40mmol 17b-hydroxyl-4-bromine-4-alkene-3-ketone-21-carboxylic acid lactone, 2mmol Cu powder, 0.2mmol BrCF 2CO 2K is in 20ml hexamethylphosphoramide HMPA solvent, at N 2Following 40-60 ℃ of reaction 8 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get the pregnant steroid of solid 17b-hydroxyl-4-trifluoromethyl-4-alkene-3-ketone-21-carboxylic acid lactone after separating with flash column chromatography, and yield is 70%,
m．p.：124.0～125.0℃。
IR(KBr?pellet)：2900，1770，1700，1638，1600，1340，1180，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：1.00(s，C 18-H)，1.28(s，C 19-H)，2.21(s，C 21-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.3(s)ppm。
MS?m/z：410(M +，5.10)，341(M +-CF 3，3.95)，337(7.90)，310(6.96)，219(12.31)，203(30.74)，149(15.35)，134(100)，55(64.44)。
High resolution mass spectrum C 22H 29O 2F 3Calculated value: 410.2069
Measured value: 410.2082.
Embodiment 5
Get 0.60mmol (25R)-4-bromine spiral shell steroid t-4-alkene-3-ketone, 0.06mmol CuI, 2mmolClCF 2CO 2K is in the 30ml dimethyl sulfoxide solvent, at N 2Following 100-120 ℃ of reaction 3 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 60ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid (25R)-4-trifluoromethyl spiral shell steroid-4-alkene-3-ketone after separating with flash column chromatography. and yield is 71%.
m．p.：218.0～219.0℃。
IR(KBr?pellet)：2900，1780，1600，1456，1346，1120，1056，980cm -1。
1H?NMR(300MHz，CDCl 3)d：0.79(d，J=6.18，3H，CH 3)，0.83(s，3H，C 18-H)，0.94(d，J=9.91Hz，CH 3)，1.27(s，C 19-H)，2.40～2.48(m，2H)，3.05(d，br，J=14.85Hz，IH)，3.35～3.50(m，2H)，4，42(dd，J=14，72，7.48Hz，1H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.6(s)ppm。
MS?m/z：382(M +，1.2)，450(0.86)，421(4.21)，411(M +-CF 3，6.74)，408(10.56)，366(18.95)，366(18.95)，351(6.44)，337(25.76)，139(100)，69(37.38)。
Ultimate analysis: C 28H 39O 3F 3Calculated value: C:69.97, H:8.18
Measured value: C:69.47, H:8.27.
Embodiment 6
Get 0.80mmol 4-bromine female steroid-4-alkene-3,17-diketone, 4mmol Cu powder, 2mmolClCF 2CO 2CH 3, in the 40ml carbon tetrachloride solvent, at N 2Following 70-80 ℃ of reaction 5 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 40ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-trifluoromethyl female steroid-4-alkene-3 after separating with flash column chromatography, the 17-diketone, and yield is 82%,
m.p.：185.6～187.0℃。
IR(KBr?pellet)：2800，1740，1690，1600，1100，1040cm -1。
1H?NMR(300MHz，CDCl 3)d：0.94(s，C 18-H)，3.48(m)ppm。
19F?NMR(60MHz，CDCl 3)d：-20.8(s)ppm。
MS?m/z：341(M ++1，26.76)，340(M +，79.37)，322(16.98)，296(46.73)，281(30.71)，271(80.69)，254(78.03)，227(32.69)，215(51.37)，145(64.81)，107(100)。
High resolution mass spectrum C 19H 23O 2F 3Calculated value: 340.1650;
Measured value: 340.1638.
Embodiment 7
Get 0.20mmol 4-bromo-N-(1, the 1-dimethyl ethyl) androstane-4-alkene-3-ketone-17b-methane amide, 0.2mmol Cu powder, lmmol FO 2SCF 2CF 2OCF 2CF 2CO 2CH 3, in 30ml hexamethylphosphoramide HMPA solvent, at N 2Following 70-80 ℃ of reaction 6 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 40ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-trifluoromethyl-N-(1, the 1-dimethyl ethyl) androstane-4-alkene-3-ketone-17b-methane amide after separating with flash column chromatography. and yield is 91%
m.p.：158.0～159.0℃。
IR(KBr?pellet)：3499(br，N-H)，2900，1680(br)，1590，1510，1450，1360，1260，1230，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.74(s，C 18-H)，1.26(s，C 19-H)，1.35(s，t-Bu)，5.08(s，N-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-20.8(s)ppm。
MS?m/z：439(M +，30.73)，424(M +-CH 3，11.6)，404(22.75)，384(11.05)，368(7.5)，339(7.95)，248(19.67)，149(51.94)，69(63.88)，57(100)。
Ultimate analysis: C 25H 36O 2NF 3Calculated value: C:68.31, H:8.25, N:3.19.
Measured value: C:68.22, H:8.31, N:2.98.
Embodiment 8
Get 0.55mmol 4-iodo-13-ethyl androstane-4-alkene-3,17-diketone, 1mmol Cu powder, 2mmol BrCF 2CO 2C 2H 5, at 30ml N, in the dinethylformamide DMF solvent, at N 2Following 30-50 ℃ of reaction 8 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 40ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-Trifluoromethyl-1 3-ethyl androstane-4-alkene-3, the 17-diketone after separating with flash column chromatography.Yield is 93%
IR(KBr?pellet)：3000，1750，1600，1346，1160，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：1.00(t，J=8.0Hz，CH 3-)，1.29(s，C 19-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.8(s)ppm。
MS?m/z：368(M +，42.7)，353(M +，11.5)，324(17.2)，299(M +-CF 3，28.4)，270(16.7)，194(100)。
Ultimate analysis: C 21H 27O 2F 3Calculated value: C:68.46, H:7.38.
Measured value: C:68.14, H:7.20.
Embodiment 9
Get 0.5mmol 4-iodo-13-ethyl-17 beta-hydroxyl-17 alphas-methyl androstane-4-alkene-3 ketone, 1mmol Cu powder, 2mmol ClCF 2CO 2C 2H 5, at 30ml N, in the dinethylformamide DMF solvent, at N 2Following 50-60 ℃ of reaction 6 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-Trifluoromethyl-1 3-ethyl-17 beta-hydroxyl-17 alphas-methyl androstane-4-alkene-3 ketone after separating with flash column chromatography. and yield is 83%
IR(KBr?pellet)：3300(br)，1690，1600，1340，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：1.00(t，J=8.0Hz，CH 3-)，1.29(s，C 19-H)，1.40(s，C 20-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-20.6(s)ppm。
MS?m/z：384(M +，1?7.6)，369(M +-CH 3，4.5)，366(M +-H 2O，19.2)，297(43.5)，194(100)。
Ultimate analysis: C 22H 31O 2F 3Calculated value: C:68.73, H:8.13.
Measured value: C:69.00, H:8.03.
Embodiment 10
Get 0.3mmol 4-iodo-N-sec.-propyl androstane-4-alkene-3-ketone-17 β-methane amide, 1mmol Cu powder, 2mmol FO 2SCF 2CF 2OCF 2CO 2CH 3, at 30ml N, in the dinethylformamide DMF solvent, at N 2Following 50-60 ℃ of reaction 6 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-trifluoromethyl-N-sec.-propyl androstane-4-alkene-3-ketone-17 β-methane amide after separating with flash column chromatography, and yield is 83%
IR(KBr?pellet)：3500(br，N-H)，2900，1680，1594，1510，1455，1356，1260，1210cm -1。
1H?NMR(300MHz，CDCl 3)d：0.75(s，C 18-H)，1.26(s，C 19-H)，1.36(d，J=6.0Hz，(CH 3) 2CH-)，4.50(q，J=6.1Hz，(CH 3) 2CH-N)，5.09(s，N-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-20.9(s)ppm。
MS?m/z：425(M +，42.6)，410(M +-CH 3，15.3)，390(20.7)，38(12.0)，366(7.6)，337(8.0)，43(100)。
Ultimate analysis: C 24H 34O 2NF 3Calculated value: C:67.74, H:8.05, N:3.29.
Measured value: C:67.68, H:7.96, N:3.32.
Embodiment 11
Get 0.6mmol 4-iodo-17 beta-hydroxy androstane-4-alkene-3-ketone, 0.06mmol Cu powder, 3mmol FO 2SCF 2CF 2OCF 2CO 2CH 3, in 30ml ethyl ketone or acetone solvent, at N 2Following 70-80 ℃ of reaction 7 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-Trifluoromethyl-1 7 beta-hydroxy androstane-4-alkene-3-ketone after separating with flash column chromatography, and yield is 78%
IR(KBr?pellet)：3300(br，-OH)，2900，1680，1600，1110，1040cm -1。
1H?NMR(300MHz，CDCl 3)d：0.86(s，C 18-H)，1.28(s，C 19-H)，4.62(t，J=8.5Hz，C 17-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.8(s)ppm。
MS?m/z：356(M +，16.4)，341(M +-CH 3，23.2)，338(M +-H 2O，8.6)，294(78.5)，192(100)。
Ultimate analysis: C 20H 27O 2F 3Calculated value: C:67.40, H:7.63.
Measured value: C:67.62, H:7.80.
Embodiment 12
Get 0.2mmol 4-bromo-17 beta-hydroxyl-17 alphas-methyl androstane-4-alkene-3-ketone-17-acetic ester, 0.8mmol Cu powder, 3mmol FO 2SCF 2CF 2OCF 2CO 2K is at 30ml N, in the dinethylformamide DMF solvent, at N 2Following 80 ℃ of reactions 4 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-Trifluoromethyl-1 7 beta-hydroxyl-17 alphas-methyl androstane-4-alkene-3-ketone-17-acetic ester after separating with flash column chromatography, and yield is 70%
IR(KBr?pellet)：2950，1750，1680，1600，1340，1110cm -1。
1H?NMR(300MHz，CDCl 3)d：0.85(s，C 18-H)，1.29(s，C 19-H)，1.40(s，C 20-H)，2.04(s，CH 3CO-)ppm
19F?NMR(60MHz，CDCl 3)d：-21.8(s)ppm。
MS?m/z：412(M +，13.4)，397(M +-CH 3，4.0)，352(M +-HOAc，24.2)，283(32.0)，197(100)。
Ultimate analysis: C 23H 31O 3F 3Calculated value: C:66.97, H:7.57.
Measured value: C:66.60, H:7.46.
Embodiment 13
Get 0.6mmol 4-bromine androstane-4-alkene-3,11,17-triketone, 3mmol CuI, 3mmolFO 2SCF 2CF 2OCF 2CF 2CO 2CH 3, at 30mlN, in the dinethylformamide DMF solvent, at N 2Following 40 ℃ of reactions 4 hours, after reaction finished, reactant diluted with ether, and with silicon bath soil elimination solid, filtrate is poured in the 50ml water and is told organic layer, and water layer is used extracted with diethyl ether again, merges organic phase, washes with water three times.The anhydrous MgSO of ether layer 4After the drying, pressure reducing and steaming solvent, head product get solid 4-trifluoromethyl androstane-4-alkene-3 after separating with flash column chromatography, and 11,17-triketone yield is 82%
IR(KBr?pellet)：3000，1750，1600，1340，1160，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.96(s，C 18-H)，1.30(s，C 19-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-22.0(s)ppm。
MS?m/z：368(M +，32.4)，353(M +-CH 3，11.4)，324(23.6)，366(M +-CF 3，28.7)，282(23.4)，204(100)。
Ultimate analysis: C 20H 23O 3F 3Calculated value: C:65.21, H:6.29.
Measured value: C:65.36, H:5.90.
Embodiment 14
Reaction conditions gets product 4-Trifluoromethyl-1 7 beta-hydroxyl-17 alphas-methyl female steroid-3-ketone with embodiment 13.Yield is 75%.
IR(KBr?pellet)：3300(br)，1680，1600，1320，1120cm -1。
1H?NMR(300MHz，CDCl 3)?d：0.90(s，C 18-H)，1.39(s，C 20-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.0(s)ppm。
MS?m/z：356(M +，17.8)，355(M +-1，26.3)，338(M +-H 2O，36.5)，310(76.4)，270(90)，107(100)。
Ultimate analysis: C 20H 27O 2F 3Calculated value: C:67.40, H:7.63.
Measured value: C:67.02, H:7.70.
Embodiment 15
Reaction conditions gets product 4-Trifluoromethyl-1 7 beta-hydroxies female steroid-4-alkene-3-ketone with embodiment 12.Yield is 87%.
IR(KBr?pellet)：3300(br，-OH)，2800，1686，1600，1106，1050cm -1。
1H?NMR(300MHz，CDCl 3)d：0.85(s，C 18-H)，4.62(t，J=8.5Hz，C 17-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.0(s)ppm。
MS?m/z：343(M ++1，16.4)，342(M +，5?4.6)，324(M +-H 2O，18.0)，297(65.4)，271(82.0)，107(100)。
12
Ultimate analysis: C 19H 25O 2F 3Calculated value: C:66.65, H:7.36.
Measured value: C:66.90, H:7.30.
Embodiment 16
Reaction conditions gets product 4-Trifluoromethyl-1 6 α with embodiment 2, the pregnant steroid of 17 α-epoxy-4-alkene-3-ketone, and yield is 88%.
IR(KBr?pellet)：3000，2900，1760，1700，1600，1440，1116cm -1。
1H?NMR(300MHz，CDCl 3)d：0.70(s，C 19-H)，1.26(s，C 19-H)，2.22(s，C 21-H)，4.90(d，J=4.0Hz，C 16-H)ppm.，
19F?NMR(60MHz，CDCl 3)d：-20.8(s)ppm。
MS?m/z：396(M +，26.3)，381(M +-CH 3，6.32)，378(M +-H 2O，28.9)，327(M +-CF 3，5.42)，284(17.4)，197(100)。
Ultimate analysis: C 22H 27O 3F 3Calculated value: C:66.65, H:6.86.
Measured value: C:66.98, H:6.66.
Embodiment 17
Reaction conditions gets the pregnant steroid of product 4-Trifluoromethyl-1 7 beta-hydroxies-16 Alpha-Methyl-4-alkene-3-ketone-17-acetic ester with embodiment 3.Yield is 85%.
IR(KBr?pellet)：2950，2800，1760，1700，1600，1460，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.70(s，C 18-H)，1.08(d，J=6.0Hz，C 16-CH 3)，1.26(s，C 19-H)，2.13(s，CH 3COO-)，2.21(s，C 21-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-21.6(s)ppm。
MS?m/z：454(M +，22.4)，439(M +-CH 3，5.6)，394(M +-H 2O，84.0)，325(43.6)，147(100)。
Ultimate analysis: C 25H 33O 4F 3Calculated value: C:66.06, H:7.32.
Measured value: C:66.31, H:7.40.
Embodiment 18
Get 0.1mmol 4-trifluoromethyl androstane-4-alkene-3, the 17-diketone, the 0.5mmol tetrachlorobenzoquinone, in 20ml dioxane solvent, reflux 2 hours is filtered, after filtrate decompression is steamed and is desolventized, solid CH 2Cl 2After the dissolving, use 5% NaHCO respectively 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl androstane-4,6-diene-3, the 17-diketone, yield is 85%.
IR(KBr?pellet)：2900，1750，1660，1600，1270，1160，1110cm -1。
1H?NMR(300MHz，CDCl 3)d：0.92(s，C 18-H)，1.30(s，C 19-H)，6.31(Complex?doublet，J=11Hz，C 6-H)，6.71(Complex?doublet，J=11Hz，C 7-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-22.6(s)ppm。
MS?m/z：352(M +，40.6)，337(M +-CH 3，10.0)，308(26.6)，283(M +-CF 3，35.3)，266(18.0)，190(100)。
Ultimate analysis: C 20H 23O 2F 3Calculated value: C:68.17, H:6.58.
Measured value: C:68.07, H:6.46.
Embodiment 19
Get 0.4mmol 4-trifluoromethyl female steroid-4-alkene-3, the 17-diketone, the 1mmol tetrachlorobenzoquinone, in 30ml dioxane solvent, reflux 6 hours is filtered, after filtrate decompression is steamed and is desolventized, solid CH 2Cl 2After the dissolving, use 5% NaHCO respectively 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl female steroid-4,6-diene-3, the 17-diketone, yield is 87%.
IR(KBr?pellet)：2850，1740，1680，1600，1100，1040cm -1。
1H?NMR(300MHz，CDCl 3)d：0.94(s，C 18-H)，6.30(Complexdoublet，J=11Hz，C 6-H)，6.71(Complex?doublet，J=11Hz，C 7-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-23.0(s)ppm。
MS?m/z：339(M ++1，28.7)，338(M +，86.5)，320(17.6)，269(100)。
Ultimate analysis: C 19H 23O 2F 3Calculated value: C:67.49, H:6.86.
Measured value: C:67.30, H:7.02.
Embodiment 20
Get 1mmol 4-trifluoromethyl-N-(1, the 1-dimethyl ethyl) androstane-4-alkene-3-ketone-17 β-methane amide, the 0.8mmol tetrachlorobenzoquinone, in the 30ml benzene solvent, reflux 15 hours is filtered, after filtrate decompression is steamed and is desolventized, solid CH 2Cl 2After the dissolving, use 5% NaHCO respectively 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl-N-(1, the 1-dimethyl ethyl) androstane-4,6-diene-3-ketone-17 β-methane amide, yield is 75%.
IR(KBr?pelle1)：3450(br，N-H)，2900，1680，1580，1260，1180，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.74(s，C 18-H)，1.30(s，C 19-H)，1.35(s，t-Bu)，6.31(Complex?doublet，J=11Hz，C 6-H)，6.71(Complex?doublet，J=11Hz，C 7-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-23.5(s)ppm。
MS?m/z：437(M +，52.0)，422(M +-CH 3，23.5)，402(27.0)，384(10.5)，346(23.8)，57(100)。
Ultimate analysis: C 25H 34O 2NF 3Calculated value: C:68.63, H:7.83, N:3.20.
Measured value: C:68.70, H:7.90, N:3.35.
Embodiment 21
Get 0.5mmol 4-Trifluoromethyl-1 3-ethyl androstane-4-alkene-3, the 17-diketone, the 2mmol tetrachlorobenzoquinone, in the 30ml benzene solvent, reflux 10 hours is filtered, after filtrate decompression is steamed and is desolventized, solid CH 2Cl 2After the dissolving, use 5% NaHCO respectively 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-Trifluoromethyl-1 3-ethyl androstane-4,6-diene-3, the 17-diketone, yield is 90%.
IR(KBr?pellet)：3000，1750，1580，1340，1160，1110cm -1。
1H?NMR(300MHz，CDCl 3)d：1.00(t，J=8.0Hz，CH 3CH 2-)，1.28(s，C 19-H)，6.30(Complex?doublet，J=11Hz，C 6-H)，6.71(Complex?doublet，J=11Hz，C 7-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-24.0(s)ppm。
MS?m/z：366(M +，28.2)，351(M +-CH 3，7.4)，337(M +-Et，4.4)，297(M +-CF 3，32.5)，194(100)。
Ultimate analysis: C 21H 25O 2F 3Calculated value: C:68.83, H:6.88.
Measured value: C:69.10, H:7.02.
Embodiment 22
Get 0.4mmol 4-trifluoromethyl-N-sec.-propyl androstane-4-alkene-3-ketone-17 β-methane amide, the 1.2mmol tetrachlorobenzoquinone, in 30ml dioxane solvent, reflux 12 hours is filtered, after filtrate decompression is steamed and is desolventized, solid CH 2Cl 2After the dissolving, use 5% NaHCO respectively 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl-N-sec.-propyl androstane-4,6-diene-3-ketone-17 β-methane amide, yield is 85%.
IR(KBr?pellet)：3500(br)，2900，1690，1600，1340，1160cm -1。
1H?NMR(300MHz，CDCl 3)d：0.75(s，C 18-H)，1.28(s，C 19-H)1.35(d，J=6.0Hz，(CH 3) 2CH-)，4.50(q，J=6.0Hz，(CH 3) 2CH-N)，5.10(s，N-H)，6.30(dm，J=11Hz，C 6-H)，6.71(dm，J=11Hz，C 7-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-24.8(s)ppm。
MS?m/z：423(M +，62.3)，408(M +-CH 3，14.2)，388(2.10)，365(18.0)，337(21.5)，43(100)。
Ultimate analysis: C 24H 32O 2NF 3Calculated value: C:28.06, H:7.16, N:3.31.
Measured value: C:27.98, H:7.40, N:3.11.
Embodiment 23
Get 0.1mmol 4-trifluoromethyl androstane-4-alkene-3, the 17-diketone, 0.5mmol dichloro dinitrile benzoquinones, in the 20ml t-butanol solvent, reflux 2 hours is filtered, and after filtrate decompression was steamed and desolventized, solid was used 5% NaHCO respectively after dissolving with EtOAc 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl androstane-1,4-diene-3, the 17-diketone, yield is 82%.
IR(KBr?pellet)：3000，1750，1600，1596，1340，1110cm -1。
1H?NMR(300MHz，CDCl 3)d：0.92(s，C 18-H)，1.48(s，C 19-H)，6.40(d，J=10Hz，C 2-H)，7.54(d，J=10Hz，C 1-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-25.0(s)ppm。
MS?m/z：352(M +，72.5)，337(M +-CH 3，8.5)，307(18.0)，283(M +-CF 3，32.6)，190(100)。
Ultimate analysis: C 20H 23O 2F 3Calculated value: C:68.17, H:6.58.
Measured value: C:68.39, H:6.34.
Embodiment 24
Get 0.4mmol 4-trifluoromethyl female steroid-4-alkene-3, the 17-diketone, 1mmol dichloro dinitrile benzoquinones, in the 30ml t-butanol solvent, reflux 4 hours is filtered, and after filtrate decompression was steamed and desolventized, solid was used 5% NaHCO respectively after dissolving with EtOAc 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl female steroid-1,4-diene-3, the 17-diketone, yield is 77%.
IR(KBr?pellet)：2810，1740，1660，1600，1100，1020cm -1。
1H?NMR(300MHz，CDCl 3)d：0.93(s，C 18-H)，6.38(d，J=10Hz，C 2-H)，7.48(dd，J=10，5.2Hz，C 1-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-24.2(s)ppm。
MS?m/z：339(M ++1，32.0)，338(M +，86.4)，320(23．4)，269(92.0)107(100)。
Ultimate analysis: C 19H 21O 2F 3Calculated value: C:67.44, H:6.26.
Measured value: C:67.40, H:6.28.
Embodiment 25
Get 0.5mmol 4-trifluoromethyl-N-(1, the 1-dimethyl ethyl) androstane-4-alkene-3-ketone-17 β-methane amide, 0.4mmol dichloro dinitrile benzoquinones, in the 30ml t-butanol solvent, reflux 8 hours is filtered, after filtrate decompression is steamed and desolventized, solid is used 5% NaHCO respectively after dissolving with EtOAc 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl-N-(1, the 1-dimethyl ethyl) androstane-1,4-diene-3-ketone-17 β-methane amide, yield is 71%.
IR(KBr?pellet)：3500(br，N-H)，2900，1680(br)，1590，1500，1440，1230，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.74(s，C 18-H)，1.35(s，t-Bu)1.90(s，C 19-H)，6.66(dd，J=4.0，2.0Hz，C 2-H)，7.70(d，J=10Hz，C 1-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-24.6(s)ppm。
MS?m/z：437(M +，42.7)，422(M +-CH 3，16.6)，402(24.6)，382(10.5)，246(22.0)，57(100)。
Ultimate analysis: C 25H 34O 2NF 3Calculated value: C:68.63, H:7.83, N:3.20.
Measured value: C:68.40, H:7.51, N:3.10.
Embodiment 26
Get 1mmol 4-Trifluoromethyl-1 3-ethyl androstane-4-alkene-3, the 17-diketone, 4mmol dichloro dinitrile benzoquinones, in the 30ml t-butanol solvent, reflux 3 hours is filtered, and after filtrate decompression was steamed and desolventized, solid was used 5% NaHCO respectively after dissolving with EtOAc 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-Trifluoromethyl-1 3-ethyl androstane-1,4-diene-3, the 17-diketone, yield is 73%.
IR(KBr?pellet)：3000，1750，1680，1600,1340，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：1.00(t，J=8.0Hz，CH 3CH 2-)，1.50(s，C 19-H)，6.30(d，J=10Hz，C 2-H)，7.46(d，J=10Hz，C 1-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-25.0(s)ppm。
MS?m/z：366(M +，32.3)，351(M +-CH 3，8.6)，337(M +-Et，6.8)，297(M +-CF 3，26.7)，194(100)。
Ultimate analysis: C 21H 25O 2F 3Calculated value: C:68.83, H:6.88.
Measured value: C:68.70, H:6.90.
Embodiment 27
Get 0.4mmol 4-trifluoromethyl-N-sec.-propyl androstane-4-alkene-3-ketone-17 β-methane amide, 1.2mmol dichloro dinitrile benzoquinones is in the 30ml t-butanol solvent, reflux 6 hours is filtered, after filtrate decompression is steamed and desolventized, solid is used 5% NaHCO respectively after dissolving with EtOAc 3Solution and water washing, after the organic phase drying, pressure reducing and steaming solvent, rapid column chromatography separate product 4-trifluoromethyl-N-sec.-propyl androstane-1,4-diene-3-ketone-17 β-methane amide, yield is 81%.
IR(KBr?pellet)：3500(br)，2900，1690，1600，1340，1120cm -1。
1H?NMR(300MHz，CDCl 3)d：0.75(s，C 18-H)，1.50(s，C 19-H)1.36(d，J=6.0Hz，(CH 3) 2CH-)，4.50(q，J=6.0Hz，(CH 3) 2CH-N)，5.09(s，N-H)，6.45(d，J=10Hz，C 2-H)，7.46(d，J=10Hz，C 1-H)ppm。
19F?NMR(60MHz，CDCl 3)d：-25.2(s)ppm。
MS?m/z：423(M +，58.6)，408(M +-CH 3，23.2)，388(22.80)，368(80.0)，339(23.6)，43(100)。
Ultimate analysis: C 24H 32O 2NF 3Calculated value: C:28.06, H:7.16, N:3.31.
Measured value: C:28.43, H:7.46, N:3.10.

Claims (8)

1、一种4-三氟甲基-3-酮-甾体化合物，其特征在于具有如下分子式： 1. A 4-trifluoromethyl-3-ketone-steroid compound, characterized in that it has the following molecular formula: 其中R1=H或CH3，R2=H或O，R3=H、CH3或C2H5，R4=OH、CH3CO、CH3COO、CONR7R8或C1-10的烷基，R5=H、CH3或CH3COO，R4和R5=O、OCH2CH2O或
Figure 9611659500022
R6=H或CH3，R5和R6=O，R7或R8=H、C1-10的烷基、环烷基，R7和R8=(CH2)n，n=1-6，
Figure 9611659500023
Figure 9611659500024
Wherein R 1 =H or CH 3 , R 2 =H or O, R 3 =H, CH 3 or C 2 H 5 , R 4 =OH, CH 3 CO, CH 3 COO, CONR 7 R 8 or C 1- 10 alkyl, R 5 =H, CH 3 or CH 3 COO, R 4 and R 5 =O, OCH 2 CH 2 O or
Figure 9611659500022
R 6 =H or CH 3 , R 5 and R 6 =O, R 7 or R 8 =H, C 1-10 alkyl, cycloalkyl, R 7 and R 8 =(CH 2 ) n , n= 1-6,
Figure 9611659500023
Figure 9611659500024
 2、一种如权利要求1所述的4-三氟甲基-3-酮-甾体化合物，其特征在于是4-三氟甲基-3-酮-4-烯、4-三氟甲基-3-酮-1，4-二烯或4-三氟甲基-3-酮-4，6-二烯的雌甾、雄甾、孕甾或螺甾化合物。2. A 4-trifluoromethyl-3-ketone-steroid compound as claimed in claim 1, characterized in that it is 4-trifluoromethyl-3-ketone-4-ene, 4-trifluoromethyl Estrogen, androster, pregnane or spirosteroids of yl-3-keto-1,4-diene or 4-trifluoromethyl-3-keto-4,6-diene. 3、一种如权利要求1所述的4-三氟甲基-3-酮-甾体化合物的制备方法，其特征在于是分别以下述方法的步骤进行：3, a kind of preparation method of 4-trifluoromethyl-3-keto-steroid compound as claimed in claim 1, it is characterized in that be to carry out with the step of following method respectively: (1)、采用分子式为：
Figure 9611659500025
(1), the molecular formula is adopted as:
Figure 9611659500025
 的4-溴或碘-3-酮-4-烯-甾体化合物原料，其中R1=H、CH3，R2=H或O，R3=H、CH3或C2H5，R4=OH、CH3CO、CH3COO、CONR7R8或C1-10的烷基，R5=H、CH3或CH3COO，R4和R5=O、OCH2CH2O或R6=H或CH3，R5和R6=O，R7或R8=H、C1-10的烷基或环烷基，R7和R8=(CH2)n，n=1-6， 在溶剂和催化剂存在下，与三氟甲基化试剂反应制得4-三氟甲基-3-酮-4-烯-甾体化合物，4-溴或碘-3-酮-4-烯-甾体化合物、催化剂和三氟甲基化试剂的克分子比为1∶0.1-5∶0.5-5，反应时间为1-10小时，反应温度为30-120℃；4-bromo or iodo-3-one-4-ene-steroid compound starting material, wherein R 1 =H, CH 3 , R 2 =H or O, R 3 =H, CH 3 or C 2 H 5 , R 4 = OH, CH 3 CO, CH 3 COO, CONR 7 R 8 or C 1-10 alkyl, R 5 = H, CH 3 or CH 3 COO, R 4 and R 5 = O, OCH 2 CH 2 O or R 6 =H or CH 3 , R 5 and R 6 =O, R 7 or R 8 =H, C 1-10 alkyl or cycloalkyl, R 7 and R 8 =(CH 2 ) n , n= 1-6, In the presence of a solvent and a catalyst, reaction with a trifluoromethylating reagent yields 4-trifluoromethyl-3-keto-4-ene-steroids, 4-bromo or iodo-3-keto-4-ene- The molar ratio of the steroid compound, the catalyst and the trifluoromethylation reagent is 1:0.1-5:0.5-5, the reaction time is 1-10 hours, and the reaction temperature is 30-120°C; (2)、4-三氟甲基-3-酮-4-烯-甾体化合物与二氯二腈基苯醌在叔丁醇溶剂中加热反应2-8小时得到4-三氟甲基-3-酮-1、4-二烯甾体化合物，其中4-三氟甲基-3-酮-4-烯-甾体化合物与二氯二腈基苯醌的克分子比为1∶0.8-5，
Figure 9611659500033
(2), 4-trifluoromethyl-3-ketone-4-ene-steroid compound and dichlorodicyanobenzoquinone were reacted by heating in tert-butyl alcohol solvent for 2-8 hours to obtain 4-trifluoromethyl- 3-keto-1,4-diene steroid compound, wherein the molar ratio of 4-trifluoromethyl-3-keto-4-ene-steroid compound to dichlorodicyanobenzoquinone is 1:0.8- 5,
Figure 9611659500033
 (3)、4-三氟甲基-3-酮-4-烯-甾体化合物与四氯苯醌在苯或二氧六环溶剂中加热反应2-15小时，得到4-三氟甲基-3-酮-4、6-二烯甾体化合物，其中4-三氟甲基-3-酮-4-烯-甾体化合物与四氯苯醌的克分子比是1∶0.8-5，
Figure 9611659500034
(3), 4-trifluoromethyl-3-keto-4-ene-steroid compound and chloranil were reacted by heating in benzene or dioxane solvent for 2-15 hours to obtain 4-trifluoromethyl -3-keto-4,6-diene steroid compound, wherein the molar ratio of 4-trifluoromethyl-3-keto-4-ene-steroid compound to chloranil is 1:0.8-5,
Figure 9611659500034
 4、一种如权利要求3所述的4-三氟甲基-3-酮-甾体化合物的制备方法，其特征在于(1)的反应中所用的溶剂是乙醚、石油醚、苯、四氯化碳、乙酮、二甲基亚砜、六甲基磷酰胺、N，N-二甲基甲酰胺、N，N-二甲基乙酰胺。4, a kind of preparation method of 4-trifluoromethyl-3-ketone-steroid compound as claimed in claim 3, it is characterized in that the solvent used in the reaction of (1) is ether, sherwood oil, benzene, four Carbon chloride, ethyl ketone, dimethylsulfoxide, hexamethylphosphoramide, N,N-dimethylformamide, N,N-dimethylacetamide. 5、一种如权利要求3或4所述的4-三氟甲基-3-酮-甾体化合物的制备方法，其特征在于(1)的反应中所用的溶剂是六甲基磷酰胺、N，N-二甲基甲酰胺、N，N-二甲基乙酰胺。5. A preparation method of 4-trifluoromethyl-3-ketone-steroid compound as claimed in claim 3 or 4, characterized in that the solvent used in the reaction of (1) is hexamethylphosphoramide, N,N-dimethylformamide, N,N-dimethylacetamide. 6、一种如权利要求3所述的4-三氟甲基-3-酮-甾体化合物的制备方法，其特征在于(1)的反应中所用的甲基化试剂是X(CF2CF2O)m(CF2)kCO2Y，其中X=Cl、Br、I或FO2S，Y=H、CH3、C2H5或K，m=0或1，k=1或2。6. A preparation method of 4-trifluoromethyl-3-keto-steroid compound as claimed in claim 3, characterized in that the methylation reagent used in the reaction of (1) is X(CF 2 CF 2 O) m (CF 2 ) k CO 2 Y, where X=Cl, Br, I or FO 2 S, Y=H, CH 3 , C 2 H 5 or K, m=0 or 1, k=1 or 2. 7、一种如权利要求3所述的4-三氟甲基-3-酮-甾体化合物的制备方法，其特征在于(1)的反应中所用的催化剂是Cu粉或CuI。7. A method for preparing 4-trifluoromethyl-3-keto-steroid compound as claimed in claim 3, characterized in that the catalyst used in the reaction of (1) is Cu powder or CuI. 8、一种如权利要求3所述的4-三氟甲基-3-酮-甾体化合物的制备方法，其特征在于反应温度为40-80℃。8. A method for preparing 4-trifluoromethyl-3-keto-steroid compound as claimed in claim 3, characterized in that the reaction temperature is 40-80°C.
CN96116595A 1996-11-29 1996-11-29 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof Expired - Fee Related CN1061983C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96116595A CN1061983C (en) 1996-11-29 1996-11-29 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96116595A CN1061983C (en) 1996-11-29 1996-11-29 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof

Publications (2)

Publication Number Publication Date
CN1161972A CN1161972A (en) 1997-10-15
CN1061983C true CN1061983C (en) 2001-02-14

Family

ID=5123690

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96116595A Expired - Fee Related CN1061983C (en) 1996-11-29 1996-11-29 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof

Country Status (1)

Country Link
CN (1) CN1061983C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002366112A (en) * 2001-06-07 2002-12-20 Hitachi Ltd Liquid crystal driving device and liquid crystal display device
CN101775055B (en) * 2009-12-30 2012-10-24 中国科学院上海有机化学研究所 Method for synthesizing 4-trifluoromethyl-4-olefine-3-steroidal ketone compound
CN104045585B (en) * 2013-03-11 2016-06-29 中国科学院上海有机化学研究所 Novel trifluoromethyl reagent and preparation thereof and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231671A1 (en) * 1985-12-26 1987-08-12 Mitsubishi Kasei Corporation Gonatriene derivatives and process for preparing them
US4753932A (en) * 1985-01-14 1988-06-28 Roussel Uclaf Novel 10-substituted steroids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753932A (en) * 1985-01-14 1988-06-28 Roussel Uclaf Novel 10-substituted steroids
EP0231671A1 (en) * 1985-12-26 1987-08-12 Mitsubishi Kasei Corporation Gonatriene derivatives and process for preparing them

Also Published As

Publication number Publication date
CN1161972A (en) 1997-10-15

Similar Documents

Publication Publication Date Title
CN1227232C (en) Process for preparing non-steroid glucocorticoid receptor regulator
CN1070907A (en) Preparation 4-replaces-1, the novel method of 4-dihydropyridine
CN1286818C (en) Method for preparing triazolinthionone derivative
CN1079216A (en) New enamides and method for making thereof and application
CN1819986A (en) Preparation of 1,3-diphenylprop-2-en-1-one derivatives
CN1027759C (en) Novel acetylcholinesterase inhibitors
CN1131219C (en) Process for preparation of phenylimidazolidine derivs.
CN1616436A (en) 4-alkoxy-cyclohexane-1-amino-carboxylic acid esters and method for the production thereof
CN1183090C (en) Process for preparing cyclopropylacrylic acid derivatives
CN1061983C (en) 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof
CN1863808A (en) Penam crystal and process for producing the same
CN1235967A (en) Carbazolone derivatives
CN1164577C (en) Process for preparing 2-amino-4-(4-fluorophenyl)-6-alkylpyrimidine-5-carboxylate
CN1095830C (en) Process for preparing alkoxyiminoacetamide derivatives
CN1179956C (en) Intermediate for preparing substituted dioxazine
CN1057297C (en) Crystals of antimicrobial compound
CN1246298C (en) Process for the preparation of ketimines
CN1791571A (en) Modafinil synthesis process.
CN1780849A (en) Process for the production of tibolone
CN1907955A (en) Method of preparing potassium phenylaminoacetate in industrial scale from acrylonitrile apparatus by-product formonitrile
CN1185208C (en) Preparation method of o-chloromethyl phenyl glyoxalic acid derivative
CN1466592A (en) 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds
CN1177814C (en) Process for preparing trione bis (oxime ether) derivatives, and trione mono-and trione bis (oxime ether) derivatives obtained thereby
CN1239502C (en) Macromolecule immobilized cinchonine alkaloid ligand, synthesis method and use thereof
CN1132823C (en) Prepn. of 2-aminothiazole derivative hydrobromate-2-isomer

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee